Vaccitech Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Vaccitech Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11087
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Vaccitech Ltd (Vaccitech) is a clinical stage company that focuses on the development of universal flu vaccines. The company is developing clinical programs for the treatment of influenza, prostate cancer, HBV, Middle East respiratory syndrome (MERS), shingles, human papillomavirus (HPV), and other therapeutic infectious diseases indications. It utilizes T cell technology platform to develop its products. Vaccitech is a spin-off company from the University of Oxford’s Jenner Institute. The company works in partnership with Emergent BioSolutions, Oxford Sciences Innovation, Batavia Biosciences, Oxford Genetics and Oxford University Innovation to research and develop clinical programs for infectious diseases and cancers. Vaccitech is headquartered in Oxford, England, the UK.

Vaccitech Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Vaccitech Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Vaccitech Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Vaccitech Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Vaccitech Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Vaccitech Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Vaccitech Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Vaccitech Raises USD27.4 Million in Series A Financing 10
Vaccitech Raises USD14.4 Million in Seed Financing Round 11
Licensing Agreements 12
Vaccitech Enters into Licensing Agreement with University of Oxford 12
Vaccitech Ltd – Key Competitors 13
Vaccitech Ltd – Key Employees 14
Vaccitech Ltd – Locations And Subsidiaries 15
Head Office 15
Recent Developments 16
Strategy And Business Planning 16
Apr 19, 2018: Driven by rapid growth Oxford Sciences Innovation expands to The Oxford Science Park 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Vaccitech Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Vaccitech Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Vaccitech Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Vaccitech Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Vaccitech Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Vaccitech Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Vaccitech Raises USD27.4 Million in Series A Financing 10
Vaccitech Raises USD14.4 Million in Seed Financing Round 11
Vaccitech Enters into Licensing Agreement with University of Oxford 12
Vaccitech Ltd, Key Competitors 13
Vaccitech Ltd, Key Employees 14

List of Figures
Vaccitech Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Vaccitech Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Vaccitech Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Vaccitech Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Vaccitech Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Vaccitech Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Vaccitech Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Vaccitech Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Vaccitech Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Mondi Plc (MNDI):企業の戦略的SWOT分析
    Mondi Plc (MNDI) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • King Country Energy Ltd:企業の戦略的SWOT分析
    King Country Energy Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Kore Potash Plc (ELM):企業の財務・戦略的SWOT分析
    Summary Kore Potash Plc (Kore Potash), formerly Elemental Minerals Ltd, is a mining company that offers exploration and development of mineral resources. The company offers development of potash project in the Republic of Congo and operates an exploration project in Australia. It also owns and opera …
  • Royal Dutch Shell Plc (RDSA):電力:M&Aディール及び事業提携情報
    Summary Royal Dutch Shell plc (Shell) is an integrated oil and gas company. The company explores for and produces oil and gas from conventional fields and sources such as tight rock, shale and coal formations. Its refining and petrochemical complexes across the world add value to its upstream produc …
  • Symantec Corporation:企業の戦略・SWOT・財務分析
    Symantec Corporation - Strategy, SWOT and Corporate Finance Report Summary Symantec Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Pakistan Petroleum Ltd (PPL):石油・ガス:M&Aディール及び事業提携情報
    Summary Pakistan Petroleum Ltd (PPL) is an upstream oil and gas company. It explores, develops and produces crude oil and natural gas resources. The company operates producing fields at Sui, Kandhkot, Adhi, Mazarani, Chachar, Adam, Adam West, Shahdadpur, Shahdadpur East and West. It also has working …
  • Hotel Grand Central Limited:企業の戦略・SWOT・財務情報
    Hotel Grand Central Limited - Strategy, SWOT and Corporate Finance Report Summary Hotel Grand Central Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Zenosense Inc (ZENO):医療機器:M&Aディール及び事業提携情報
    Summary Zenosense Inc (Zenosense) is a medical device company that develops transformational medical diagnostic technologies. The company develops MIDS Cardiac, a hand held cardiac diagnostic device that applies patent-protected magnetic nanoparticle detection technology used for the rapid testing o …
  • America Movil, SA DE C.V.:企業の戦略・SWOT・財務情報
    America Movil, SA DE C.V. - Strategy, SWOT and Corporate Finance Report Summary America Movil, SA DE C.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Jones Lang LaSalle Inc (JLL):企業の財務・戦略的SWOT分析
    Jones Lang LaSalle Inc (JLL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Exar Corporation:企業のM&A・事業提携・投資動向
    Exar Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Exar Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • ING Groep NV:戦略・SWOT・企業財務分析
    ING Groep NV - Strategy, SWOT and Corporate Finance Report Summary ING Groep NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • X-Chem Inc-製薬・医療分野:企業M&A・提携分析
    Summary X-Chem Inc (X-Chem) is a biotechnology company that focuses on applying its innovative drug discovery platform to the generation of novel small molecule therapeutics. The company’s drug discovery engine is based on a library generated by iterative combinatorial synthesis of small molecules. …
  • China Railway Signal & Communication Corp Ltd:企業の戦略・SWOT・財務情報
    China Railway Signal & Communication Corp Ltd - Strategy, SWOT and Corporate Finance Report Summary China Railway Signal & Communication Corp Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, opera …
  • CONSOL Energy Inc.:企業のM&A・事業提携・投資動向
    CONSOL Energy Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's CONSOL Energy Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Vitabiotics Ltd:企業の戦略的SWOT分析
    Vitabiotics Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Syros Pharmaceuticals Inc (SYRS):企業の財務・戦略的SWOT分析
    Summary Syros Pharmaceuticals Inc (Syros) is a biopharmaceutical company that develops medicines for the treatment of cancer, immune-mediated diseases, and other diseases. The company offers its pipeline products under clinical trials include SY-1425, an oral, potent and selective RARa agonist that …
  • American Eagle Outfitters Inc:企業の戦略・SWOT・財務情報
    American Eagle Outfitters Inc - Strategy, SWOT and Corporate Finance Report Summary American Eagle Outfitters Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Alliance Resource Partners LP:企業の戦略・SWOT・財務情報
    Alliance Resource Partners LP - Strategy, SWOT and Corporate Finance Report Summary Alliance Resource Partners LP - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • EnerVest Ltd:企業のM&A・事業提携・投資動向
    EnerVest Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's EnerVest Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆